Over The Counter Drugs Market

Over-the-counter Drugs - Global Market Outlook (2018-2027)

4.8 (68 reviews)
Published: March 2020 ID: SMRC18980
4.8 (68 reviews)
Published: March 2020 ID: SMRC18980

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Over-the-counter Drugs market is accounted for $125.00 billion in 2018 and is expected to reach $237.66 billion by 2027 growing at a CAGR of 7.4% during the forecast period. While the factors like the inclination of pharmaceutical companies toward OTC drugs from RX drugs and favorable regulatory framework are the factors fueling the growth of the market. However, lack of awareness in the rural area is restraining the market growth.

Over-the-counter drugs, also known as non-prescription drugs, refer to medicines that can be bought without a prescription. These drugs are safe and effective when a consumer follows the directions on the label or as provided by a physician. Over-the-counter (OTC) drugs are primarily used to treat conditions that do not require direct consultation of a doctor. OTC drugs are safe and well-tolerated. These provide affordable treatment and also help to decrease the workload of physicians. The OTC drugs help to build a diverse product portfolio for the health care business of pharmaceutical companies also it helps to extend product range for consumer brands of consumer goods companies.

Based on type, weight loss/dietary products segment is likely to have a huge demand in the forecast period due to the rising awareness of the general population about health and rise in the consumption of junk food, which is leading to the rise in lifestyle-related diseases. By geography, North America is estimated to have a huge demand owing to the leading trend among pharmaceutical companies to switch from Rx to OTC drugs.

Some of the key players in Over-the-counter Drugs Market include GlaxoSmithKline PLC, Emami Limited, Abbott Laboratories, Dabur India Limited, Procter & Gamble, Reckitt Benckiser, Sun Pharmaceuticals Limited, Cipla Inc, Company, Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd, Sanofi, Boehringer Ingelheim, Novartis, and Pfizer.

Mode of Intake Covered:
• Topical
• Oral
• Parenteral

Types Covered:
• Analgesics
• Weight Loss/Dietary Products
• Gastrointestinal Products
• Cold, Cough and Flu Products
• Mineral and Vitamin Supplements
• Skin Products
• Ophthalmic Products
• Sleeping Aids
• Dermatology Products    

End Users Covered:
• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies    

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.